CAS RN: 494753-69-4

Ginsenoside RK2

Product Availability

Choose a grade to view its available package options.

10 package records4 with current stock3 grade groups
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250131 100mg Out of stock Inquiry
Batchno.20260227 10mg In stock Inquiry
Batchno.20251121 25mg In stock Inquiry
Batchno.20251201 50mg In stock Inquiry
Batchno.20250107 5mg In stock Inquiry
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20260511 10mg Out of stock Inquiry
Batchno.20250312 1mg Out of stock Inquiry
Batchno.20250130 25mg Out of stock Inquiry
Batchno.20260518 5mg Out of stock Inquiry
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20260605 1mg Out of stock 5-7 business days Inquiry
  • Product code: starshine_CAS494753-69-4
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

494753-69-4 / (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Standard CAS: 494753-69-4 Multi CAS: Yes

Basic Information

CAS
494753-69-4
Multi CAS
Yes
Molecular Formula
C42H70O12
Molecular Weight
767.000000
Exact Mass
766.486728
InChI
InChI=1S/C42H70O12/c1-21(2)10-9-11-22(3)23-12-16-42(8)30(23)24(45)18-28-40(6)15-14-29(39(4,5)27(40)13-17-41(28,42)7)53-38-36(34(49)32(47)26(20-44)52-38)54-37-35(50)33(48)31(46)25(19-43)51-37/h10,23-38,43-50H,3,9,11-20H2,1-2,4-8H3/t23-,24-,25-,26-,27+,28-,29+,30+,31-,32-,33+,34+,35-,36-,37+,38+,40+,41-,42-/m1/s1
InChIKey
KWDWBAISZWOAHD-MHOSXIPRSA-N

Computed Properties

Structural Parameters

Heavy atom count
54
Fraction Csp3
0.9
Rotatable bonds
10
H-bond acceptors
12
H-bond donors
8
Molar refractivity
199.47
TPSA
198.76

LogP / Solubility

WLOGP
2.95
MLOGP
2.67
XLogP3
5.4
Consensus LogP
3.67
Log S (ESOL)
-5.8
Class (ESOL)
Slightly soluble
Log S (Ali)
-7.98
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-8.3
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-5.3

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Get In Touch

Contact Us